Current and Emerging Treatment Options for Hypertriglyceridemia: State-of-the-Art Review
Hypertriglyceridemia (HTG) is associated with a residual risk of atherosclerotic cardiovascular disease. Extremely elevated triglyceride (TG) concentrations, particularly due to familial chylomicronemia syndrome (FCS), pose a risk for acute pancreatitis. Standard therapies with statins, fibrates, om...
Shranjeno v:
| Principais autores: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI AG
2025-01-01
|
| Serija: | Pharmaceuticals |
| Teme: | |
| Online dostop: | https://www.mdpi.com/1424-8247/18/2/147 |
| Oznake: |
Brez oznak, prvi označite!
|